Developing and validating model systems for immuno-oncology.

Abstract

Owing to clinical success of immune-checkpoint blockade, immunotherapy is becoming a cornerstone of modern oncology, and immuno-oncology is at the forefront of basic cancer research. This commentary outlines future opportunities for immuno-oncology modeling.

More about this publication

Cancer cell
  • Publication date 04-06-2021

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.